Free Trial
NASDAQ:MAZE

Maze Therapeutics (MAZE) Stock Price, News & Analysis

Maze Therapeutics logo
$14.49 +0.22 (+1.54%)
As of 08/29/2025 04:00 PM Eastern

About Maze Therapeutics Stock (NASDAQ:MAZE)

Key Stats

Today's Range
$13.89
$14.85
50-Day Range
$10.33
$17.78
52-Week Range
$6.71
$19.19
Volume
358,404 shs
Average Volume
285,479 shs
Market Capitalization
$635.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.60
Consensus Rating
Buy

Company Overview

Receive MAZE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MAZE Stock News Headlines

He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dollar portfolio today… Back then… one financial expert begged people to look at Nvidia -- when it was trading at just $1.10! Now… he’s urging you to look at a new group of seven stocks…tc pixel
See More Headlines

MAZE Stock Analysis - Frequently Asked Questions

Maze Therapeutics' stock was trading at $13.38 on January 1st, 2025. Since then, MAZE stock has increased by 8.3% and is now trading at $14.49.

Maze Therapeutics, Inc. (NASDAQ:MAZE) issued its quarterly earnings data on Tuesday, August, 12th. The company reported ($0.77) earnings per share for the quarter, topping analysts' consensus estimates of ($0.79) by $0.02.

Maze Therapeutics (MAZE) raised $140 million in an IPO on Friday, January 31st 2025. The company issued 8,750,000 shares at a price of $16.00 per share.

Maze Therapeutics's lock-up period expired on Wednesday, July 30th. Maze Therapeutics had issued 8,750,000 shares in its IPO on January 31st. The total size of the offering was $140,000,000 based on an initial share price of $16.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the end of the lock-up period.

Top institutional investors of Maze Therapeutics include Frazier Life Sciences Management L.P. (10.42%), Geode Capital Management LLC (0.53%), Octagon Capital Advisors LP (0.41%) and Boothbay Fund Management LLC (0.17%).

Shares of MAZE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/12/2025
Today
9/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MAZE
Previous Symbol
NASDAQ:MAZE
CIK
1842295
Web
N/A
Fax
N/A
Employees
121
Year Founded
N/A

Price Target and Rating

High Price Target
$34.00
Low Price Target
$17.00
Potential Upside/Downside
+76.7%
Consensus Rating
Buy
Rating Score (0-4)
3.29
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
13.63
Quick Ratio
13.63

Sales & Book Value

Annual Sales
$167.50 million
Price / Sales
3.79
Cash Flow
$0.15 per share
Price / Cash Flow
94.65
Book Value
($7.11) per share
Price / Book
-2.04

Miscellaneous

Outstanding Shares
43,850,000
Free Float
N/A
Market Cap
$635.39 million
Optionable
N/A
Beta
N/A

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:MAZE) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners